✦ LIBER ✦

26 A phase I clinical study of human CNS stem cells (HUCNS-SC) in patients with neuronal ceroid lipofuscinosis

✍ Scribed by Robert Steiner; T. Koch; A. Al-Uzri; N. Uchida; S. Tamaki; A. Tsukamoto; D. Guillaume; N. Selden

Book ID: 116988083
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 45 KB
Volume: 92
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2007.08.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

Phase I/II clinical and pharmacokinetic

Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck

✍ Lars Bastholt; Lena Specht; Kenneth Jensen; Eva Brun; Annika Loft; Jørgen Peters 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase I rapid dose-escalation study of A

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

✍ Emmanuel S. Antonarakis; Michael A. Carducci; Mario A. Eisenberger; Samuel R. De 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 316 KB